Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies ... third quarter of 2025 and submitting an investigational new drug application (IND) ...

CollPlant Biotechnologies , or 'CollPlant', a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue ...

CompanyOverview|NASDAQ:GILD] Gilead Sciences Inc. (NASDAQ: GILD) stock surged to a new 52-week high at $106.69 recently on ...

Xilio Therapeutics announces collaboration with AbbVie for tumor-activated immunotherapies ... 2025 and submitting an investigational new drug application (IND) in the first quarter of 2027.

Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including masked T cell engagers, with $52.0 million in upfront payments Extended ant ...

Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections Inspira announced its bio-electronic ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

Christopher Boone, global head of health economics and outcomes research at AbbVie, advises ... to get to state where there is more widespread application of them, a more systematic approach ...

The death took place recently in Chicago, USA of Julie Corduff. The deceased was the daughter of Kate and Peter Sheridan RIP, ...

AbbVie reported better-than-expected fourth-quarter earnings. Strong demand for the company's Skyrizi and Rinvoq autoimmune therapeutics has helped offset the decline in Humira sales since losing ...

AbbVie's Rinvoq and Skyrizi could eventually surpass Humira's peak sales. The dividend is well-funded, though an expensive acquisition spree may lead to slower growth. The stock's solid growth ...

and the new headwind in the form of Medicare Part D benefit design which represents an additional headwind AbbVie needs to absorb. The pipeline is also progressing nicely. There are five new ...